SANTA MONICA, Calif. – GoodRx has announced that the newly FDA-approved Wegovy pill (oral semaglutide) is now available at a cash price of $149 per month at more than 70,000 pharmacies nationwide via GoodRx. For consumers looking to easily evaluate their options for both treatment and access to the medication, they will soon be able to connect with a licensed healthcare provider through GoodRx for Weight Loss to determine eligibility and obtain a prescription when appropriate. The arrival of the Wegovy pill on GoodRx represents a significant step forward in making GLP-1 treatments more affordable and accessible for people looking to begin or advance their weight-loss journey.
CDR
“We’re excited to help consumers access one of the most anticipated weight-loss treatments on the market,” said Wendy Barnes, President and CEO of GoodRx. “As new oral GLP-1 options emerge, GoodRx is uniquely positioned to support patients as they navigate their treatment choices. By combining transparent cash pricing with streamlined access to care and broad pharmacy availability, we're helping usher in a simpler, more consumer-friendly chapter in weight management treatment.”
Lowest Discounted Cash Prices for First Oral GLP-1
The Wegovy pill is now available on GoodRx to eligible self-pay patients at a cash price of $149 per month for the two lowest doses (1.5mg and 4mg). With industry-leading cash prices across all FDA-approved doses and availability at more than 70,000 retail pharmacies nationwide, GoodRx ensures that consumers can access the Wegovy pill quickly, reliably, and with meaningful savings.
A Streamlined Path Through GoodRx for Weight Loss
Consumers who need help determining whether the Wegovy pill is appropriate for them will soon be able to turn to GoodRx for Weight Loss, the company’s telemedicine subscription that is designed specifically for people seeking weight management support. Through this offering, users can meet with licensed healthcare providers, discuss treatment options, complete eligibility assessments, and—when clinically appropriate—receive a prescription for the Wegovy pill or other FDA-approved GLP-1 treatments. GoodRx for Weight Loss also provides ongoing support, clear pricing, and flexible fulfillment options.
Supporting Pharma Manufacturers With Scalable Cash-Pay Solutions
The introduction of these new lowest discounted cash prices for the Wegovy pill demonstrates how GoodRx can help pharmaceutical manufacturers bring new cash-pay programs to market quickly and at scale. With millions of consumers turning to GoodRx each month to evaluate medication affordability options, manufacturers can immediately surface clear, competitive pricing to patients on day one of availability. GoodRx’s extensive pharmacy network, trusted brand, and established consumer engagement channels enable partners to rapidly scale awareness, streamline access, and accelerate adoption.
